Science
Mechanism of Action
This decapeptide functions by interfering with components of the SNARE complex, which is essential for the release of acetylcholine at the neuromuscular junction. By diminishing acetylcholine release, it effectively weakens facial muscle contractions. Furthermore, some botulinum-like peptides can inhibit calcium-dependent pathways involved in neurotransmitter exocytosis, further reducing muscle activity and consequently smoothing dynamic wrinkles.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Peptides generally exhibit susceptibility to structural alterations and inactivation from variations in temperature, hydration, organic solvent exposure, or pH levels. While botulinum toxins demonstrate stability, often within a pH range of 5-6 (specifically 5.4-5.8), and even broader stability (pH 2.7-10.2 for type C toxin), specific stability data for S-CLOSTRIDIUM BOTULINUM DECAPEPTIDE-2 is currently unavailable.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not specifically assessed S-CLOSTRIDIUM BOTULINUM DECAPEPTIDE-2. Although cosmetic peptides are often considered safe, a comprehensive safety evaluation necessitates specific ingredient reviews. It is crucial to distinguish this topical peptide from botulinum *toxin*, which is regulated by the FDA as an injectable drug with distinct safety warnings.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While demonstrating a promising mechanism for wrinkle reduction, a definitive verdict on the efficacy and safety of S-CLOSTRIDIUM BOTULINUM DECAPEPTIDE-2 in cosmetic applications requires further targeted clinical research and specific safety assessments.
Related
Similar Ingredients
Finding similar ingredients…